Indrayani Biotech Ltd.
Snapshot View

81.45 +5.95 ▲7.9%

08 February 2023, 10:21:00 AM
Volume: 34,726

Overview View Details >>

Sector Agriculture Compare with Sector peers
Industry Floriculture Compare with Industry peers
Website http://www.indrayani.com
Market Cap 258.42 Cr.
Enterprise Value(EV) 305.51 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.33 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 56.94 Trailing Twelve Months Ending 2022-09
Industry PE 70.75 Trailing Twelve Months Ending 2022-09
Book Value / Share 13.04 Trailing Twelve Months Ending 2022-09
Price to Book Value 5.79 Calculated using Price: 75.50
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 3.42 Cr. 34,227,192 Shares
FaceValue 10
Company Profile
The company was incorporated on March 9, 1992 and it was converted into a public limited company on March 13, 1992. It is into floriculture and is engaged in the cultivation of cut flowers, plantlets and seeds.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+7.88%
1 Week
+12.58%
1 Month
+5.71%
3 Month
-10.54%
6 Month
+39.23%
1 Year
+190.37%
2 Year
+832.99%
5 Year
+1451.43%
10 Year
5 years 2011-03 2012-03 2020-03 2021-03 2022-03
Return on Equity (%) -2.84 -1.85 43.42 -112.29 20.23
Return on Capital Employed (%) 16.17 7.69 7.85 -23.16 16.38
Return on Assets (%) -0.87 -0.59 2.53 -24.50 9.71

Balance Sheet View Details >>

Particulars 6 years 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 4 3 31 20 24 54
Non Curr. Liab. 2 0 7 8 7 27
Curr. Liab. 4 9 14 12 19 50
Minority Int. 0 0 -10
Equity & Liab. 10 12 51 40 51 121
Non Curr. Assets 6 6 32 31 32 67
Curr. Assets 4 7 19 9 19 54
Misc. Exp. not W/O 0
Total Assets 10 12 51 40 51 121

Profit Loss View Details >>

Particulars 6 years 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 39 58 50 21 62 100
Other Income 0 0 0 0 3
Total Income 39 58 50 21 62 103
Total Expenditure -39 -57 -47 -26 -55 -88
PBIDT 1 1 3 -5 7 15
Interest 0 0 -1 -2 -2 -3
Depreciation 0 0 -1 0 -1 -2
Taxation 0 0 0
Exceptional Items -4
PAT 0 0 1 -11 4 10
Minority Interest 0 -5
Share Associate 0
Other Related Items
Consolidated Net Profit 0 0 1 -11 4 5
Adjusted EPS 0 0 2 -3 1 1

Cash Flow View Details >>

Particulars 5 years 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 2 6 0 4
Cash Fr. Inv. -3 0 -4 -1 -1
Cash Fr. Finan. 2 -1 -1 0 -3
Net Change 0 1 1 -1 1
Cash & Cash Eqvt 0 1 1 1 2

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 50.75 50.39 50.39 50.39 50.17 48.81 44.91 44.89 44.89
Public 49.25 49.61 49.61 49.61 49.83 51.19 55.09 55.11 55.11
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 06 Feb 2023
Board Meeting Intimation for Considering Unaudited Financial Results Pursuant To Regulation 29 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 Scheduled To Be Held On Tuesday February 14 2023.
INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve 1. The Unaudited Financial Results (standalone and consolidated) of the Company for the quarter ended December 31 2022. 2. Any other business with the permission of the Chair.
Fri, 13 Jan 2023
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Operation Management Of Vaasan Medical Center (India) Private Limited.
We wish to inform that the Operation Management of Vaasan Medical Center India Private Limited is being taken over by IBL Healthcare Limited a wholly-owned subsidiary of Indrayani Biotech Limited.
Sat, 07 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 we are enclosing herewith the copy of Certificate received from M/s. Link Intime India Private Limited the Registrar and Transfer Agent (RTA) of the Company for the Quarter ended December 31 2022.

Technical Scans View Details >>

Tue, 07 Feb 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Tata Consumer Products Ltd. 67,636.69 723.45 -0.6%
Shree Renuka Sugars Ltd. 9,961.33 46.70 0.0%
E.I.D. - Parry (India) Ltd. 9,278.84 518.80 -0.6%
Balrampur Chini Mills Ltd. 7,394.81 359.85 -0.9%
CCL Products (India) Ltd. 7,151.58 533.00 -0.9%
Triveni Engineering & Industries Ltd. 6,417.39 266.95 +0.6%
Bombay Burmah Trading Corporation Ltd. 6,331.10 908.30 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2022-12 58.68 723.45 -0.6%
Shree Renuka Sugars Ltd. Consolidated 2022-09 0.00 46.70 0.0%
E.I.D. - Parry (India) Ltd. Consolidated 2022-09 8.83 518.80 -0.6%
Balrampur Chini Mills Ltd. Consolidated 2022-09 25.69 359.85 -0.9%
CCL Products (India) Ltd. Consolidated 2022-12 30.40 533.00 -0.9%
Triveni Engineering & Industries Ltd. Consolidated 2022-12 3.75 266.95 +0.6%
Bombay Burmah Trading Corporation Ltd. Consolidated 2022-09 0.00 908.30 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2022-12 4.28 723.45 -0.6%
Shree Renuka Sugars Ltd. Consolidated 2022-09 -4.90 46.70 0.0%
E.I.D. - Parry (India) Ltd. Consolidated 2022-09 1.61 518.80 -0.6%
Balrampur Chini Mills Ltd. Consolidated 2022-09 2.70 359.85 -0.9%
CCL Products (India) Ltd. Consolidated 2022-12 5.07 533.00 -0.9%
Triveni Engineering & Industries Ltd. Consolidated 2022-12 1.86 266.95 +0.6%
Bombay Burmah Trading Corporation Ltd. Consolidated 2022-09 1.18 908.30 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Tata Consumer Products Ltd. Consolidated 2022-03 0.07 723.45 -0.6%
Shree Renuka Sugars Ltd. Consolidated 2022-03 -2.94 46.70 0.0%
E.I.D. - Parry (India) Ltd. Consolidated 2022-03 0.15 518.80 -0.6%
Balrampur Chini Mills Ltd. Consolidated 2022-03 0.44 359.85 -0.9%
CCL Products (India) Ltd. Consolidated 2022-03 0.52 533.00 -0.9%
Triveni Engineering & Industries Ltd. Consolidated 2022-03 0.82 266.95 +0.6%
Bombay Burmah Trading Corporation Ltd. Consolidated 2022-03 1.07 908.30 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2022-03 7.28 723.45 -0.6%
Shree Renuka Sugars Ltd. Consolidated 2022-03 0.00 46.70 0.0%
E.I.D. - Parry (India) Ltd. Consolidated 2022-03 31.81 518.80 -0.6%
Balrampur Chini Mills Ltd. Consolidated 2022-03 16.80 359.85 -0.9%
CCL Products (India) Ltd. Consolidated 2022-03 17.53 533.00 -0.9%
Triveni Engineering & Industries Ltd. Consolidated 2022-03 21.07 266.95 +0.6%
Bombay Burmah Trading Corporation Ltd. Consolidated 2022-03 26.01 908.30 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2022-03 7.28 723.45 -0.6%
Shree Renuka Sugars Ltd. Consolidated 2022-03 0.00 46.70 0.0%
E.I.D. - Parry (India) Ltd. Consolidated 2022-03 31.81 518.80 -0.6%
Balrampur Chini Mills Ltd. Consolidated 2022-03 16.80 359.85 -0.9%
CCL Products (India) Ltd. Consolidated 2022-03 17.53 533.00 -0.9%
Triveni Engineering & Industries Ltd. Consolidated 2022-03 21.07 266.95 +0.6%
Bombay Burmah Trading Corporation Ltd. Consolidated 2022-03 26.01 908.30 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2022-03 12,425.37 723.45 -0.6%
Shree Renuka Sugars Ltd. Consolidated 2022-03 6,432.63 46.70 0.0%
E.I.D. - Parry (India) Ltd. Consolidated 2022-03 23,531.50 518.80 -0.6%
Balrampur Chini Mills Ltd. Consolidated 2022-03 4,846.03 359.85 -0.9%
CCL Products (India) Ltd. Consolidated 2022-03 1,462.03 533.00 -0.9%
Triveni Engineering & Industries Ltd. Consolidated 2022-03 4,290.94 266.95 +0.6%
Bombay Burmah Trading Corporation Ltd. Consolidated 2022-03 14,544.29 908.30 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2022-03 1,078.95 723.45 -0.6%
Shree Renuka Sugars Ltd. Consolidated 2022-03 -136.72 46.70 0.0%
E.I.D. - Parry (India) Ltd. Consolidated 2022-03 1,572.98 518.80 -0.6%
Balrampur Chini Mills Ltd. Consolidated 2022-03 452.69 359.85 -0.9%
CCL Products (India) Ltd. Consolidated 2022-03 204.35 533.00 -0.9%
Triveni Engineering & Industries Ltd. Consolidated 2022-03 364.91 266.95 +0.6%
Bombay Burmah Trading Corporation Ltd. Consolidated 2022-03 1,424.99 908.30 +0.2%

FAQ's On Indrayani Biotech Ltd.

What is Indrayani Biotech share price?

Can I buy Indrayani Biotech shares now?

What is the Market Cap of Indrayani Biotech?

What are the key metrics to analyse Indrayani Biotech?

What is the 52 Week High and Low of Indrayani Biotech?

What is the trend of Indrayani Biotech share price?